Head to head for first-timers
CoreAge Rx vs Next Vial
CoreAge Rx and Next Vial both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxNext Vial
Rank #180 for first-timers · Grade C
Mama-Match
Best for: A mom who wants a real monthly price, with a large discount available if a year up front is possible.
Visit Next VialThe verdict for a first step
CoreAge Rx edges out Next Vial on the Mama-Match Score, 94 to 53 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Next Vial is still a genuine option — the plan selector is one of the cleanest I have seen: $199 a month, or $169, $149 and $99 over three, six and twelve months, and I checked every division — they are exact. Semaglutide and tirzepatide cost the same. And then you look at the top of that same page: "Doctor-Led Weight Loss Plans as Low as $249.97/Month". That figure is nowhere in the selector, and it is two and a half times what its cheapest plan costs. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | Next Vial |
|---|---|---|
| Mama-Match Score | 94/100 · A | 53/100 · C |
| Overall rank | #1 | #180 |
| Semaglutide | $99/mo | $199/mo paying month to month |
| Tirzepatide | $149/mo | $199/mo paying month to month |
| Coverage | All 50 states | Not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
Next Vial
Rank #180 · Grade C
What we like
- A genuine month-to-month option at $199, not just prepaid plans
- Every total divides exactly: $507, $894, $1,188, $477, $834 and $948
- Semaglutide and tirzepatide cost the same, so switching molecules costs nothing
The caveats
- ⛔ The headline on that same page says "as low as $249.97/Month", above every plan it offers
- The $99 rate requires $1,188 up front
- The microdose route starts at three months; there is no single month
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Next Vial with the other providers we review for women.
Or browse the full comparison hub.